Online first
Original article
Published online: 2024-09-25
Evaluating the effect of coronary atherosclerosis on the occurrence of atrial fibrillation through coronary computed tomography angiography
Pubmed: 39377616
Abstract
Background: The direct impact of atherosclerotic lesions in coronary vessels on the occurrence of atrial fibrillation (AF) in patients without a history of acute myocardial ischemia, previous myocardial infarction, or revascularization procedures remains largely unknown.
Aims: To assess the risk and predictors of new-onset AF in patients with coronary atherosclerosis confirmed by coronary computed tomography angiography (CCTA).
Methods: We included consecutive patients referred for CCTA who had been observed and diagnosed with new-onset AF over 10 years.
Results: Of the 549 patients enrolled in the study, 208 (37.9%) were diagnosed with atherosclerotic lesions in the coronary vessels and 63 (11.5%) developed AF during the 10 years of observation. Patients with AF were older (61.8 [10.4] years vs. 58.3 [9.2] years; P = 0.005), had an enlarged left atrium in the anteroposterior dimension (38.2 [7.2] mm vs. 34.4 [5.4] mm; P < 0.001), and had a widened interventricular septum (12.3 [2.0] mm vs. 11.0 [2.1] mm; P < 0.001). We also found a significant correlation between the occurrence of AF in patients with coronary atherosclerotic lesions and with increased thickness of the interventricular septum relative to the posterior wall of the left ventricle (P = 0.017).
Conclusions: Our data indicate an association between coronary atherosclerosis and the greater risk of AF in patients with increased thickness of the interventricular septum relative to the posterior wall of the left ventricle. This finding suggests that by using CCTA we can predict which patients are at higher risk of developing AF.
Keywords: atrial fibrillationchronic coronary syndromecomputed tomography of coronary arteriescoronary artery diseasecoronary atherosclerosis
References
- Gautier A, Picard F, Ducrocq G, et al. CLARIFY investigators . New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry. Eur Heart J. 2024; 45(5): 366–375.
- Michniewicz E, Mlodawska E, Lopatowska P, et al. Patients with atrial fibrillation and coronary artery disease - Double trouble. Adv Med Sci. 2018; 63(1): 30–35.
- Montalescot G, Sechtem U, Achenbach S, et al. Task Force Members, ESC Committee for Practice Guidelines, Document Reviewers. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013; 34(38): 2949–3003.
- Kirchhof P, Benussi S, Kotecha D, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37(38): 2893–2962.
- Gensini GF, Comeglio M, Colella A. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J. 1998; 19 Suppl A: A53–A61.
- Christodoulidis G, Vittorio TJ, Fudim M, et al. Inflammation in coronary artery disease. Cardiol Rev. 2014; 22(6): 279–288.
- Liang F, Wang Yi. Coronary heart disease and atrial fibrillation: a vicious cycle. Am J Physiol Heart Circ Physiol. 2021; 320(1): H1–H12.
- Liu H, Southern DA, Arena R, et al. Cardiac Rehabilitation and Risk of Incident Atrial Fibrillation in Patients With Coronary Artery Disease. Can J Cardiol. 2022; 38(10): 1621–1628.
- Goto S, Bhatt DL, Röther J, et al. REACH Registry Investigators. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J. 2008; 156(5): 855–63, 863.e2.
- Lau DH, Huynh LT, Chew DP, et al. Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Am J Cardiol. 2009; 104(10): 1317–1323.
- Kosmidou I, Chen S, Kappetein AP. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial. J Am Coll Cardiol. 2018; 71(7): 739–748.
- Wang CL, Chen PC, Juang HT, et al. Adverse Outcomes Associated with Pre-Existing and New-Onset Atrial Fibrillation in Patients with Acute Coronary Syndrome: A Retrospective Cohort Study. Cardiol Ther. 2019; 8(1): 117–127.
- Benedetto U, Gaudino MF, Dimagli A. Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery. Circulation. 2020; 142(14): 1320–1329.
- Tomaszuk-Kazberuk A, Koziński M, Kuźma Ł, et al. Atrial fibrillation is more frequently associated with nonobstructive coronary lesions: the Bialystok Coronary Project. Pol Arch Intern Med. 2020; 130(12): 1029–1036.
- Chen LY, Leening MJG, Norby FL, et al. Carotid Intima-Media Thickness and Arterial Stiffness and the Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study, Multi-Ethnic Study of Atherosclerosis (MESA), and the Rotterdam Study. J Am Heart Assoc. 2016; 5(5).
- Rybicki FJ, Udelson JE, Peacock WF, et al. Emergency Department Patients With Chest Pain Writing Panel, Emergency Department Patients With Chest Pain Rating Panel, Appropriate Utilization of Cardiovascular Imaging Oversight Committee. 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force. J Am Coll Radiol. 2016; 13(2): e1–e29.
- Taylor AJ, Cerqueira M, Hodgson JM, et al. American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society of Cardiovascular Computed Tomography, American College of Radiology, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, North American Society for Cardiovascular Imaging, Society for Cardiovascular Angiography and Interventions, Society for Cardiovascular Magnetic Resonance. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. Circulation. 2010; 122(21): e525–e555.
- Stolzmann P, Scheffel H, Leschka S, et al. Reference values for quantitative left ventricular and left atrial measurements in cardiac computed tomography. Eur Radiol. 2008; 18(8): 1625–1634.
- Kannel WB, Abbott RD, Savage DD, et al. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J. 1983; 106(2): 389–396.
- AFFIRM Investigators. Atrial Fibrillation Follow-up Investigation of Rhythm Management. Baseline characteristics of patients with atrial fibrillation: the AFFIRM Study. Am Heart J. 2002; 143(6): 991–1001.
- Xu X, Zhou Q, Ren Z, et al. Evaluation of Patients with Angiographically-Confirmed Coronary Artery Disease to Investigate the Association Between Epicardial Fat Thickness and Atrial Fibrillation. Med Sci Monit. 2022; 28: e936446.
- Schmitt J, Duray G, Gersh BJ, et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009; 30(9): 1038–1045.
- Zielonka A, Tkaczyszyn M, Mende M, et al. Atrial fibrillation in outpatients with stable coronary artery disease: results from the multicenter RECENT study. Pol Arch Med Wewn. 2015; 125(3): 162–171.
- Romanov A, Martinek M, Pürerfellner H, et al. Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study. Europace. 2018; 20(2): 263–270.
- Sinno H, Derakhchan K, Libersan D, et al. Atrial ischemia promotes atrial fibrillation in dogs. Circulation. 2003; 107(14): 1930–1936.
- Skalidis EI, Hamilos MI, Karalis IK, et al. Isolated atrial microvascular dysfunction in patients with lone recurrent atrial fibrillation. J Am Coll Cardiol. 2008; 51(21): 2053–2057.
- Range FT, Schäfers M, Acil T, et al. Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation. Eur Heart J. 2007; 28(18): 2223–2230.
- Weijs B, Pisters R, Haest RJ, et al. Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls. Heart Rhythm. 2012; 9(12): 1923–1929.
- Pokorney SD, Berchuck SI, Chiswell K, et al. Atrial branch coronary artery stenosis as a mechanism for atrial fibrillation. Heart Rhythm. 2022; 19(8): 1237–1244.
- Verrier RL, Fuller H, Justo F, et al. Unmasking atrial repolarization to assess alternans, spatiotemporal heterogeneity, and susceptibility to atrial fibrillation. Heart Rhythm. 2016; 13(4): 953–961.
- Nishida K, Qi XY, Wakili R, et al. Mechanisms of atrial tachyarrhythmias associated with coronary artery occlusion in a chronic canine model. Circulation. 2011; 123(2): 137–146.
- Shiroshita-Takeshita A, Sakabe M, Haugan K, et al. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs. Circulation. 2007; 115(3): 310–318.
- Bhatia HS, McClelland RL, Heckbert SR, et al. Density of Calcified Coronary Artery Plaque and Risk of Incident Atrial Fibrillation (from the Multiethnic Study of Atherosclerosis). Am J Cardiol. 2022; 179: 39–45.
- Theodorakis GΝ. Coronary artery disease and atrial fibrillation. Hellenic J Cardiol. 2017; 58(3): 213–214.
- Loncaric F, Nunno L, Mimbrero M, et al. Basal Ventricular Septal Hypertrophy in Systemic Hypertension. Am J Cardiol. 2020; 125(9): 1339–1346.
- Alkema M, Spitzer E, Soliman OII, et al. Multimodality Imaging for Left Ventricular Hypertrophy Severity Grading: A Methodological Review. J Cardiovasc Ultrasound. 2016; 24(4): 257–267.
- Garg PK, O'Neal WT, Chen LY, et al. American Heart Association's Life Simple 7 and Risk of Atrial Fibrillation in a Population Without Known Cardiovascular Disease: The ARIC (Atherosclerosis Risk in Communities) Study. J Am Heart Assoc. 2018; 7(8).
- Ogunmoroti O, Michos ED, Aronis KN, et al. Life's Simple 7 and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2018; 275: 174–181.
- Kosmidou I, Liu Y, Zhang Z, et al. Incidence and Prognostic Impact of Atrial Fibrillation After Discharge Following Revascularization for Significant Left Main Coronary Artery Narrowing. Am J Cardiol. 2020; 125(4): 500–506.
- Masunaga N, Ogawa H, Minami K, et al. Fushimi AF Registry Investigators. Association of Concomitant Coronary Artery Disease With Cardiovascular Events in Patients With Atrial Fibrillation - The Fushimi AF Registry. Circ J. 2022; 86(8): 1252–1262.
- Verheugt FWA, Ambrosio G, Atar D, et al. GARFIELD-AF Investigators. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF. Am J Med. 2019; 132(12): 1431–1440.e7.
- Lamberts M, Gislason GH, Lip GYH, et al. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study. Circulation. 2014; 129(15): 1577–1585.
- Pencina MJ, Navar AM, Wojdyla D, et al. Quantifying Importance of Major Risk Factors for Coronary Heart Disease. Circulation. 2019; 139(13): 1603–1611.
- Kawel N, Turkbey EB, Carr JJ, et al. Normal left ventricular myocardial thickness for middle-aged and older subjects with steady-state free precession cardiac magnetic resonance: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging. 2012; 5(4): 500–508.
- Bicudo LS, Tsutsui JM, Shiozaki A, et al. Value of real time three-dimensional echocardiography in patients with hypertrophic cardiomyopathy: comparison with two-dimensional echocardiography and magnetic resonance imaging. Echocardiography. 2008; 25(7): 717–726.
- Greupner J, Zimmermann E, Grohmann A, et al. Head-to-head comparison of left ventricular function assessment with 64-row computed tomography, biplane left cineventriculography, and both 2- and 3-dimensional transthoracic echocardiography: comparison with magnetic resonance imaging as the reference standard. J Am Coll Cardiol. 2012; 59(21): 1897–1907.
- Walker JR, Abadi S, Solomonica A, et al. Left-sided cardiac chamber evaluation using single-phase mid-diastolic coronary computed tomography angiography: derivation of normal values and comparison with conventional end-diastolic and end-systolic phases. Eur Radiol. 2016; 26(10): 3626–3634.
- Juneau D, Erthal F, Clarkin O, et al. Mid-diastolic left ventricular volume and mass: Normal values for coronary computed tomography angiography. J Cardiovasc Comput Tomogr. 2017; 11(2): 135–140.
- Walpot J, Juneau D, Massalha S, et al. Left Ventricular Mid-Diastolic Wall Thickness: Normal Values for Coronary CT Angiography. Radiol Cardiothorac Imaging. 2019; 1(5): e190034.
